Literature DB >> 10893581

Combination of symptom score, flow rate and prostate volume for predicting bladder outflow obstruction in men with lower urinary tract symptoms.

G S Steele1, M P Sullivan, D J Sleep, S V Yalla.   

Abstract

PURPOSE: The severity of lower urinary tract symptoms associated with benign prostatic enlargement correlates poorly with bladder outlet obstruction. Since urodynamic studies are presumed to be relatively complex, invasive and not cost-effective, they are not routinely performed by physicians treating men with lower urinary tract symptoms. As a result, a large number of patients are treated for bladder outlet obstruction when in fact obstruction may not be present. Since other noninvasive methods have not been effective for predicting bladder outlet obstruction, we investigated whether a combination of prostate volume, uroflowmetry and the American Urological Association (AUA) symptom index would be reliable for predicting this condition.
MATERIALS AND METHODS: We prospectively evaluated 204 men with a mean age plus or minus standard deviation of 66.7 +/- 7.5 years who presented with lower urinary tract symptoms. Each patient completed an AUA symptom index questionnaire and underwent uroflowmetry, post-void residual urine volume measurement, pressure flow study and transrectal ultrasound of the prostate to estimate prostatic volume. We constructed receiver operating characteristics curves using various threshold values for maximum urine flow and prostate volume. Threshold values for maximum urine flow and prostate volume were used alone and combined with the AUA symptom index for predicting bladder outlet obstruction. We selected a cutoff value for maximum urine flow of 10 or less ml. per second and prostate volume of 40 gm. or greater, and used these values with an AUA symptom index of greater than 20 to predict bladder outlet obstruction in the group overall.
RESULTS: Differences in the mean symptom index score in men with and without bladder outlet obstruction were not statistically significant. There was no obstruction in 19%, 28.9% and 35% of those with severe, moderate and mild symptoms, respectively. The selected cutoff values of maximum urine flow, prostate volume and symptom score combined correctly predicted obstruction in all 39 patients. Therefore, our combination of cutoff values proved to be highly accurate for predicting bladder outlet obstruction. Sensitivity, specificity, and positive and negative predictive values were 26%, 100%, 100% and 32%, respectively.
CONCLUSIONS: Our study showed that combining the AUA symptom index, maximum urine flow and prostate volume reliably predicted bladder outlet obstruction in a small subset of patients only. Although bladder outlet obstruction was correctly predicted by our threshold values of AUA symptom index, maximum urine flow and prostate volume in only 39 men (26%) with obstruction, these patients represent a substantial group in any large urological practice treating male lower urinary tract symptoms.

Entities:  

Mesh:

Year:  2000        PMID: 10893581

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  16 in total

Review 1.  Is multichannel urodynamic assessment necessary before considering a surgical treatment of BPH? Pros and cons.

Authors:  Xavier Biardeau; Mohamed A Elkoushy; Shachar Aharony; Mostafa Elhilali; Jacques Corcos
Journal:  World J Urol       Date:  2015-07-28       Impact factor: 4.226

2.  Effect of transurethral resection of the prostate based on the degree of obstruction seen in urodynamic study.

Authors:  Dong Suk Min; Hee Ju Cho; Jung Yoon Kang; Tag Keun Yoo; Jeong Man Cho
Journal:  Korean J Urol       Date:  2013-12-10

3.  BPH nomogram using IPSS, prostate volume, peak flow rate, PSA and median lobe protrusion for predicting the need for intervention: development and internal validation.

Authors:  Arvind P Ganpule; Rohan S Batra; Nitiraj B Shete; Abhishek G Singh; Ravindra B Sabnis; Mahesh R Desai
Journal:  Am J Clin Exp Urol       Date:  2021-06-15

4.  Detrusor overactivity is associated with downregulation of large-conductance calcium- and voltage-activated potassium channel protein.

Authors:  Shaohua Chang; Cristiano Mendes Gomes; Joseph A Hypolite; James Marx; Jaber Alanzi; Stephen A Zderic; Bruce Malkowicz; Alan J Wein; Samuel Chacko
Journal:  Am J Physiol Renal Physiol       Date:  2010-04-14

5.  Bladder outlet obstruction number: a good indicator of infravesical obstruction in patients with benign prostatic enlargement?

Authors:  Damir Aganovic; Hajrudin Spahovic; Alden Prcic; Osman Hadziosmanovic
Journal:  Bosn J Basic Med Sci       Date:  2012-08       Impact factor: 3.363

6.  MR imaging-guided cryoablation for the treatment of benign prostatic hyperplasia.

Authors:  Pejman Ghanouni; Harcharan Gill; Elena Kaye; Kim Butts Pauly; Bruce Daniel
Journal:  J Vasc Interv Radiol       Date:  2011-10       Impact factor: 3.464

7.  Lower urinary tract symptoms, prostate volume, uroflowmetry, residual urine volume and bladder wall thickness in Turkish men: a comparative analysis.

Authors:  Levent Işikay; K Turgay Akgül; Bariş Nuhoğlu; Gürhan Ozdemir; Ali Ayyildiz; Taner Cavumirza; Cankon Germiyanoğlu
Journal:  Int Urol Nephrol       Date:  2007-03-02       Impact factor: 2.370

8.  Non-invasive parameters predicting bladder outlet obstruction in Korean men with lower urinary tract symptoms.

Authors:  Min-Yong Kang; Ja Hyeon Ku; Seung-June Oh
Journal:  J Korean Med Sci       Date:  2010-01-19       Impact factor: 2.153

9.  Perirenal fat stranding on CT: is there an association with bladder outlet obstruction?

Authors:  Na Y Han; Deuk J Sung; Min J Kim; Beom J Park; Ki C Sim; Sung B Cho
Journal:  Br J Radiol       Date:  2016-04-28       Impact factor: 3.039

10.  Alteration of the PKC-mediated signaling pathway for smooth muscle contraction in obstruction-induced hypertrophy of the urinary bladder.

Authors:  Shaohua Chang; Joseph A Hypolite; Sunish Mohanan; Stephen A Zderic; Alan J Wein; Samuel Chacko
Journal:  Lab Invest       Date:  2009-04-20       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.